BlackRock, Inc. 13D and 13G filings for Zynerba Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-10 10:39 am Sale |
2020-06-30 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
BlackRock Inc. BLK |
438,643 1.800% |
-1,074,962 (-71.02%) |
Filing |